chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 month after 2nd dose of vaccine i became very short of breath went to the dr on 6/25/2021 was told i had allergies  went to work in and on 7/18/2021 I passed out in the hotel shower was taken to the hospital where they found 3 clots in my lungs and a dvt in right leg
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 20-APR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2008, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the long-term prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. Later in 2008, the patient was treated for the onset of severe vesicular rash which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Mother reports patient was complaining of pain which started around 6 PM the day of the vaccines. He kept saying it was pain like his "bone was broken".  She gave him motrin and he stopped complaining. However, the next day she started to notice the muscle function slowly decreasing. She reports she didn't notice until she gave him a glass of milk in his left hand that he dropped. Earlier in the day he also asked her to peel his banana, which he usually can do on his own. That morning he also asked her to button his shirt and help pull on his pants which she thought was just related to the local reaction in the arm. Mom reports that later that afternoon she noticed weakness in the flexion of the elbow, then  no longer moving fingers, and then dropping of the wrist. He complained of pain in the wrist and the forearm only. She reports she gave another dose of motrin and massaged the areas with olive oil.  His mom reports that he had total resolution of symptoms over about 6 hours or so, by 4 AM 9/1/2017 muscle function was all normal again. She reports that her niece had a similar reaction to Hep B vaccine and that she had no use of her arm for 6 weeks. She reports that she had to undergo physical and occupational therapy and required a brace for her hand and writ. She does not have any effects that have lingered. Patient's mother asking me to report this event to the VAERS in case it returns or he has additional issues in the future.
Erythema of Hands and Feet, given steroids in ED.  Infectious Disease doctor saw patient and thought it was a reaction to the thimerosal.
A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a rash within 3 days of receiving the first shot of Pfizer Biontech COVID vaccine. Reporter said the physician thought it might be a resurface of shingles. Rash cleared subsequently without any further complications. The outcome of the event rash was recovered while unknown for the event shingles.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Patient given vaccine out of age range.  Patient was 16 years old at time of vaccination.
Nasal congestion; dry mouth; non-productive cough; mild headache; mild muscle aches; Diagnosed with Covid-19; Diagnosed with Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP)via Pfizer sales representative. The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administration date 06May2021 (Lot number: ER8733) at the age of 57 years as dose 2, single and administration date 13Apr2021 (Lot number: EW0158) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Nov2021, outcome "unknown" and all described as "Diagnosed with Covid-19"; NASAL CONGESTION (non-serious), outcome "unknown", described as "Nasal congestion"; DRY MOUTH (non-serious), outcome "unknown", described as "dry mouth"; COUGH (non-serious), outcome "unknown", described as "non-productive cough"; HEADACHE (non-serious), outcome "unknown", described as "mild headache"; MYALGIA (non-serious), outcome "unknown", described as "mild muscle aches". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (15Nov2021) unknown results. Clinical course:Diagnosed with Covid-19 with Pfizer provided self-test, and confirmed by separate HCP test on Monday, 15Nov2021. Nasal congestion, dry mouth, non-productive cough, mild headache, mild muscle aches. No fever.   Follow-Up (24Nov2021):Follow-up attempts are completed. No further information is expected.
Pt received 2nd COVID vaccination at 1024. Once in observation area, pt became unresponsive shortly after sitting down. This provider was called over by staff to pt, which was noted to have dropped her water bottle and become unresponsive while sitting in the chair. Pt remained in the chair, did not fall or injure self. Upon arrival to patient, she was noted to have moderate pallor, with shallow, slow breathing, no cyanosis noted. Her head was aligned/adjusted to maintain an open airway. Pt noted to have some muscular rigidity and not verbally responsive. Another provider advised to call 911 due to unresponsiveness and seizure-like activity. 911 called @1027, meanwhile pt lifted and placed into a wheelchair and moved to treatment area where vitals were obtained, patient became verbally responsive @1034, responses/speech was clear but slow, pt was oriented to self, place, time and situation. Oxygen applied via facemask @4L. Pt provided staff with phone number to call her mother who was notified of daughter's condition @1032. FD Engine arrival @1033 report given and pt also became more responsive, eyes opened and stated clearly that she was feeling better. Pt color also improved. Pt denied any allergies, PMH or hx of seizure activity. Pt only reported a syncope many years ago. Ambulance arrival @1036, report provided to emergency staff and pt taken to ambulance for further evaluation @1039. Pt returned to vaccine clinic @1052, having declined ambulance transport. When asked about events, pt stated that upon sitting down she felt a sudden onset of moderate nausea and reached for her water bottle in her bookbag, pt states she could not recall or hear anything until she was moved to wheelchair, and did not recall how she came to be in the observation area (based on this information, suspected time unconscious was approx 6-12 seconds). Pt was educated regarding the many causes of syncope and the neccesity for further evaluation in the Emergency department. Pt discouraged from driving herself from the clinic and was able to obtain ride from her roommate. Pt urged again to obtain a ride to the hospital for further evaluation, understanding verbalized and agreed with plan of care.
A nurse reported that a 45 year old female received an injection of Pnu-Imune 23 on 98/18/00. On 09/20/00, she developed nausea, vomiting and numbness in her chest and stomach. Her symptoms resolved prior to being seen by the physician on 10/02/00. Additional info received on 11/15/00 indicated that the patient was allergic to x-ray dye, nitrofurantoin, sulfa, aspirin, hydrocodone / acetaminiphen, oxycodone / acetaminophen and troglitazone.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent condition, medical history and drug reactions/allergies were not reported. On 08-FEB-2018 the patient was vaccinated with one dose of improperly stored VARIVAX (lot # N023960, expiry date: 01-SEP-2019), (dose, frequency and route were not reported) for prophylaxis. It was reported that the vaccine was reconstituted with a properly stored sterile diluent (manufacturer unknown). VARIVAX was exposed to temperature of 6 degree Fahrenheit (F) to 14 F for 36 minutes. No adverse effects reported. Product quality complaint was not involved. There was no previous temperature excursion reported. The digital data logger was involved. Sender's Comments: US-009507513-1803USA003566: US-009507513-1803USA003698: US-009507513-1803USA003686: US-009507513-1803USA003696: US-009507513-1803USA003699: US-009507513-1803USA003695.
Tongue swelling; Tight chest; Wheezing; Very tired; Migraine; Worsemuscles hurt; This is a spontaneous report from a contactable consumer, the patient. A 57-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 24Mar2021 at 01:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, fibromyalgia, pseudotumor cerebri, arthritis and the patient was allergic to latex, sting, PCN and fruit. Concomitant medications included tizanidine (MANUFRATURER UNKNOWN), erenumab (AIMOVIG), famotidine (MANUFRATURER UNKNOWN), pregabalin(LYRICA) and hydromorphone hydrochloride (DILAUDID), all were from unknown date and for unspecified indication. The patient previously received thimerosol (MANUFRATURER UNKNOWN), naproxen (MANUFRATURER UNKNOWN), promethazine, penicillin (MANUFRATURER UNKNOWN), prochlorperazine malate (MANUFRATURER UNKNOWN), droperidol (MANUFRATURER UNKNOWN), codeine (MANUFRATURER UNKNOWN) , acetazolamide (DIAMOX), povidone iodine (MANUFRATURER UNKNOWN) , ceftazidime (MANUFRATURER UNKNOWN), trimethobenzamide (MANUFRATURER UNKNOWN) , buprenorphone; naloxone (SUBOXONE), cefuroxime (ZINACEF), methadone (MANUFRATURER UNKNOWN) and polymyxin topical (MANUFRATURER UNKNOWN), all on unknown date and for unspecified indication and patient experienced drug allergy. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  On 25Mar2021 at 02:00, the patient experienced tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt. The patient did not receive any treatment for adverse event. The clinical outcome of the events tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt was recovered on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
pt recvd vax & 5 days later had a fever of 103 & the following day broke out w/measles; had a complete case of the measles rash covered entire body;
Pfizer vaccine was administered outside of facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------ J96.00 ACUTE RESPIRATORY FAILURE 1/12/2022 ACUTE RESPIRATORY FAILURE R09.02 HYPOXEMIA 1/12/2022 ACUTE RESPIRATORY FAILURE
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The reporter reported that because their facility had not been able to download the digital data logger, they had been put on hold at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment was made. There had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because the facility was unable to download the digital data logger, this issue was treated as a temperature excursion. The reporter was unable to download the data logger for the months of December 2021, January 2022 and February 2022. The reporter was filling out a temperature excursion assessment.  The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing and no adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
Pt. recieved vaccine greater than 12 hours after drawn up. No adverse event. MD contacted pt. Pt. declined revaccination.
No additional information provided; Expired vaccine used; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported.   On 17-FEB-2022, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA (Lot# T027114 and expiration date 07-FEB-2022) (exact dose and frequency were not reported) as prophylaxis. (expired product administered). The vaccine did not experience temperature excursion. No additional adverse event reported, no further information provided.
Received booster shot on 5/19/2022, started severe vomiting and extremely dizzy stayed in bed all day 5/20/2022. May 21st 22nd and 23rd vertigo was bad. On May 25th sever vomiting again sever Vertigo, and numbing in left arm, went to the ER was there until May 27th.  EKG and MRI came back  normal, Hospital treated her for vertigo follow up with L. We were brought here. All other vaccines were Pfizer.
This is a non serious spontaneous case from a pharmacist of Burning Sensation in Eye. The reporter causality was not provided to FluMist. A pharmacist reported loss of voice, sore throat, runny nose, cough, the burning sensation in the left nostril, and eye area in a 50 year old female after receiving her first FluMist dose on 21Oct04. The reporter would not disclose the pt's history or contact information. On 26Oct04 the pt stated to the reporter that one day after receiving FluMist she had a burning sensation in her left nostril. She also had a runny nose and congestion which subsided by 29Oct04. On 29Oct04 the pt complained of cough, sore throat and loss of voice. The burning sensation in her nostril remained and had spread to her eye area. No further information is available.
Hives/urticaria of face, arms, legs, and trunk occurring several hours after immunization, and lasting 1 wk. as of today. Treatment included BENADRYL 25 mg daily and prednisone.
Chills, presenting discomfort . Then they give him a bath. When they went to report to the nurse of each of the residents, they found him without vital signs.
Child was given inadvertently an adult Hep A instead of a peds. Hep A spoke with CDC immunization hotline. Referred to complete VAERS form.
Sometime during the night of July 15th 2021 Pat had a massive stroke. There was no warning that day she had lunch with her daughter and she was fine.
Headache, Sedation, Myalgia, Arthralgia, Fever, chills Narrative:  Other Relevant History:
Extreme joint pain and muscle weakness beginning at right arm and eventually spreading to left arm and then to both legs. Prescribed Prednisone so that limbs would function. Still seeing medical professionals for cause and treatment.
Engerix-B given 5/1/06. Seen in office on 5/3/06. Developed site rxn few hours after vaccination.
Presents to emergency department in the early care after the patient was witnessed to have a syncopal event. The patient went into urgent care today because of increasing complications of fever shakes and chills and uncontrollable twitch. Patient had first evidence of these symptoms 2 days ago on Saturday while at work. The patient had uncontrollable shaking episode but eventually it subsided and he drove himself home as opposed to being taken to the hospital. The patient has been ambulating at home but not his typical way he seems to move with holding onto structures and needing to have assistance. The patient has not fallen or cause any injury. The patient has complained of headaches he usually does not have headaches.
Pt recv vax on 10/8/98; on same day pt exp left knee stiffness w/ swelling
Extreme itching (painful) in legs and arms, preventing sleep, not controlled by benedryl.  On 2nd day Dr prescribed larger dose of hydroxyzine.  I was still itching all day long but it was gone the next morning, day 2 after my shot.
Myalgia, Arthralgia, lower back pain down to heels Narrative: Lower back pain down to his heels, cannot tolerate sitting or standing still, laying down was the only thing that help, feels fatigued and weak, doesn't feel like he has his usual strength. Missed 2 days of work. No fever. Has bilateral elbow pain. Does not feel like he is sick, just feels like he needs to rest.
Patients deltoid area where shot was given has redness, heat, and is swollen to the size of a golfball. Ice was applied and Motrin given by mom.
9/14: "Mom called stating pt received some vaccines last week and now pt has some redness around the injection site about a quarter size. Mom was concerned that it was more toward the inner thigh. She did notice redness the day of the vaccine. He is not showing any signs of distress related to his heart and is otherwise well. He is on a pulse ox and has has no issues. Mom does feel like his more fussy than normal but she also believes he is getting some teeth. He has had no fever and no breathing difficulty."F 9/16: "Mom called back.  Reports the following: Patient developed a bruise with circumscribed redness to the injection site on the right inner thigh." 9/17: 1 cm x 1.5 cm bruise noted around vaccine insertion site; no redness or swelling noted, skin is not warm to the touch.  Parents have been monitoring.
My younger brother had local muscle pain around the injection site, a slightly elevated body temperature (99.9 F according to an ear thermometer), fatigue, and chills.  No treatment was given except I had him remain in an air-conditioned room and wear loose clothing.  He recovered by this morning from the elevated temperature, chills, and fatigue.  There is still local muscle pain around the injection site.
This spontaneous report as received from a consumer's mother via Sanofi Pasteur MSD refers to her daughter of unknown age. The reporter stated that her daughter was once a young healthy cheerleader. Beauty pageant queen, and a personal trainer. She loved life and was very active with a promising career ahead of her. On an unknown date, the patient was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). There was no concomitant medication provided. On an unknown date, her health rapidly declined. She ended up in a wheelchair not able to walk for two years and her immune system was shot, so she got sick all of the time. She could not work, drive, or live a normal life. She fall all of the time and it was all that she could do to get a shower and eat without being exhausted. The primary reporter also stated that GARDASIL had ruined her daughter's life. The outcome of abasia, malaise, fall, immune system disorder was unknown, and the outcome of impaired work ability and daily living impaired was not recovered as she still cannot live a normal life. The reporter considered abasia, activities of daily living impaired, impaired work ability, malaise, fall, fatigue and immune system disorder to be related to GARDASIL. Upon internal review, she was not able to walk for two years, impaired work ability and daily living impaired were determined to be serious due to disability. Additional information is not expected because the reporter details were not provided.
Swelling of bicep near inside of elbow and pain and rednes of bicep.  Patient states reaction began as itching approx 4 inches on inside of arm above elbow.  Swelling worse next am in back of arm and bicep area.  Some redness.
Headache, tired, and woke with cold chills . Possible low fever but didn't verify.
pon receiving the vaccine at 09:12 am he immediately said he felt nauseous and his hearing in his right ear was buzzing. Also he stated he was getting dizzy. Pt appeared pale and was almost about to lose consciousness.  RN was called and blood pressure machine was pulled to begin blood pressure measurements. Patient then began to perspire but was vocal with wanting water. Patients initial blood pressure was low  but slowly began to rise. His initial blood pressure was 91/60, heart rate of 83 and  O2 sat of 99%.   Dr.  was consulted and talked to patient before EMS arrived to evaluate. His vitals before leaving the clinic was blood pressure of 114/57, heart rate of 70 and O2 sat of 98%.
Received SP vaccine on 3/15/02. On 3/22/02, primary response. On 4/4/02, continued drainage. No lymphangitis. Impetiginous eruption around resolving primary reaction to vaccinia vaccination. No scab. On 4/8, resolved.